Center Laboratories, Inc. (TPEX:4123)
Taiwan
· Delayed Price · Currency is TWD 34.20
-0.10 (-0.29%)
Apr 24, 2025, 1:30 PM CST
Center Laboratories Revenue
In the year 2024, Center Laboratories had annual revenue of 1.62B TWD with 16.06% growth. Center Laboratories had revenue of 448.55M in the quarter ending December 31, 2024, with 10.61% growth.
Revenue
1.62B
Revenue Growth
+16.06%
P/S Ratio
15.23
Revenue / Employee
n/a
Employees
n/a
Market Cap
24.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.62B | 223.86M | 16.06% |
| Dec 31, 2023 | 1.39B | 626.29M | 81.58% |
| Dec 31, 2022 | 767.72M | 267.62M | 53.51% |
| Dec 31, 2021 | 500.11M | -216.94M | -30.25% |
| Dec 31, 2020 | 717.05M | -720.63M | -50.12% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.82B |
| Lumosa Therapeutics | 39.15M |